{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:53:46Z","timestamp":1785423226184,"version":"3.56.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81930119"],"award-info":[{"award-number":["81930119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171182"],"award-info":[{"award-number":["82171182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Beijing","award":["Z190024"],"award-info":[{"award-number":["Z190024"]}]},{"name":"Tianjin Science and Technology Project","award":["22ZYCGSY00840"],"award-info":[{"award-number":["22ZYCGSY00840"]}]},{"name":"Science and Technology Project of Tianjin Municipal Health Committee","award":["ZC20121"],"award-info":[{"award-number":["ZC20121"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-052B"],"award-info":[{"award-number":["TJYXZDXK-052B"]}]},{"name":"Science and Technology Planning Program of Beijing Municipal Science\n& Technology Commission and Administrative Commission of Zhongguancun Science Park","award":["Z231100004823012"],"award-info":[{"award-number":["Z231100004823012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-024-00575-z","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T13:07:22Z","timestamp":1726664842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Blood\u2013brain barrier breakdown in dementia with Lewy bodies"],"prefix":"10.1186","volume":"21","author":[{"given":"Jinghuan","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"issue":"Suppl 1","key":"575_CR1","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1017\/cjn.2016.2","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan DB, Fiest KM, Roberts JI, Maxwell CJ, Dykeman J, Pringsheim T, Steeves T, Smith EE, Pearson D, Jett\u00e9 N. The prevalence and incidence of dementia with lewy bodies: a systematic review. Can J Neurol Sci. 2016;43(Suppl 1):S83-95.","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"575_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","volume":"10","author":"JPM Kane","year":"2018","unstructured":"Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, et al. Clinical prevalence of Lewy body dementia. Alzheimers Res Ther. 2018;10(1):19.","journal-title":"Alzheimers Res Ther"},{"key":"575_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.05.022","volume":"29","author":"W Yue","year":"2016","unstructured":"Yue W, Wang XD, Shi Z, Wang Y, Ji Y. The prevalence of dementia with Lewy bodies in a rural area of China. Parkinsonism Relat Disord. 2016;29:72\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"575_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.976753","volume":"16","author":"J Gan","year":"2022","unstructured":"Gan J, Liu S, Wang F, Shi Z, L\u00fc Y, Niu J, Meng X, Cai P, Wang XD, Chen Z, et al. Association between prevalence rate of dementia with Lewy bodies and sleep characteristics in Chinese old adults. Front Hum Neurosci. 2022;16: 976753.","journal-title":"Front Hum Neurosci"},{"issue":"4","key":"575_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clineuro.2005.06.005","volume":"108","author":"J Deng","year":"2006","unstructured":"Deng J, Zhou DH, Li J, Wang YJ, Gao C, Chen M. A 2-year follow-up study of alcohol consumption and risk of dementia. Clin Neurol Neurosurg. 2006;108(4):378\u201383.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"575_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"JP Taylor","year":"2020","unstructured":"Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ, O\u2019Brien JT. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19(2):157\u201369.","journal-title":"Lancet Neurol"},{"issue":"1","key":"575_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12883-021-02169-w","volume":"21","author":"J Gan","year":"2021","unstructured":"Gan J, Liu S, Wang X, Shi Z, Shen L, Li X, Guo Q, Yuan J, Zhang N, You Y, et al. Clinical characteristics of Lewy body dementia in Chinese memory clinics. BMC Neurol. 2021;21(1):144.","journal-title":"BMC Neurol"},{"issue":"8","key":"575_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jamda.2016.03.017","volume":"17","author":"I Zahirovic","year":"2016","unstructured":"Zahirovic I, Wattmo C, Torisson G, Minthon L, Londos E. Prevalence of dementia with Lewy body symptoms: a cross-sectional study in 40 Swedish nursing homes. J Am Med Dir Assoc. 2016;17(8):706\u201311.","journal-title":"J Am Med Dir Assoc"},{"issue":"7","key":"575_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/mds.29044","volume":"37","author":"E Bayram","year":"2022","unstructured":"Bayram E, Coughlin DG, Litvan I. Sex differences for clinical correlates of Alzheimer\u2019s pathology in people with Lewy body pathology. Mov Disord. 2022;37(7):1505\u201315.","journal-title":"Mov Disord"},{"key":"575_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2022.06.004","volume":"101","author":"YY Wong","year":"2022","unstructured":"Wong YY, Wu CY, Yu D, Kim E, Wong M, Elez R, Zebarth J, Ouk M, Tan J, Liao J, et al. Biofluid markers of blood\u2013brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2022;101:119.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"575_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12916-022-02404-2","volume":"20","author":"P Guo","year":"2022","unstructured":"Guo P, Gong W, Li Y, Liu L, Yan R, Wang Y, Zhang Y, Yuan Z. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer\u2019s disease and Parkinson\u2019s disease: a large-scale multi-trait association analysis. BMC Med. 2022;20(1):214.","journal-title":"BMC Med"},{"issue":"1","key":"575_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69.","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"575_CR13","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s11357-020-00211-2","volume":"42","author":"ICM Verheggen","year":"2020","unstructured":"Verheggen ICM, de Jong JJA, van Boxtel MPJ, Gronenschild E, Palm WM, Postma AA, Jansen JFA, Verhey FRJ, Backes WH. Increase in blood\u2013brain barrier leakage in healthy, older adults. Geroscience. 2020;42(4):1183\u201393.","journal-title":"Geroscience"},{"issue":"6","key":"575_CR14","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3390\/ijms22062860","volume":"22","author":"Y Moon","year":"2021","unstructured":"Moon Y, Lim C, Kim Y, Moon WJ. Sex-related differences in regional blood\u2013brain barrier integrity in non-demented elderly subjects. Int J Mol Sci. 2021;22(6):2860.","journal-title":"Int J Mol Sci"},{"issue":"7806","key":"575_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D\u2019Orazio LM, et al. APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"key":"575_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neurobiolaging.2019.09.017","volume":"85","author":"WM Freeze","year":"2020","unstructured":"Freeze WM, Jacobs HIL, de Jong JJ, Verheggen ICM, Gronenschild E, Palm WM, Hoff EI, Wardlaw JM, Jansen JFA, Verhey FR, et al. White matter hyperintensities mediate the association between blood\u2013brain barrier leakage and information processing speed. Neurobiol Aging. 2020;85:113\u201322.","journal-title":"Neurobiol Aging"},{"key":"575_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.570045","volume":"13","author":"A Michalicova","year":"2020","unstructured":"Michalicova A, Majerova P, Kovac A. Tau protein and its role in blood\u2013brain barrier dysfunction. Front Mol Neurosci. 2020;13: 570045.","journal-title":"Front Mol Neurosci"},{"key":"575_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.695479","volume":"15","author":"D Wang","year":"2021","unstructured":"Wang D, Chen F, Han Z, Yin Z, Ge X, Lei P. Relationship between amyloid-\u03b2 deposition and blood\u2013brain barrier dysfunction in Alzheimer\u2019s disease. Front Cell Neurosci. 2021;15: 695479.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"575_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-023-01199-5","volume":"15","author":"X Lv","year":"2023","unstructured":"Lv X, Zhang M, Cheng Z, Wang Q, Wang P, Xie Q, Ni M, Shen Y, Tang Q, Gao F. Changes in CSF sPDGFR\u03b2 level and their association with blood\u2013brain barrier breakdown in Alzheimer\u2019s disease with or without small cerebrovascular lesions. Alzheimers Res Ther. 2023;15(1):51.","journal-title":"Alzheimers Res Ther"},{"key":"575_CR20","doi-asserted-by":"publisher","first-page":"1390036","DOI":"10.3389\/fnagi.2024.1390036","volume":"16","author":"M Li","year":"2024","unstructured":"Li M, Gan J, Yang X, Liu S, Ji Y. Cerebrospinal fluid\/serum albumin ratio in patients with Lewy body disease: a systematic review and meta-analysis. Front Aging Neurosci. 2024;16:1390036.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"575_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3233\/JAD-200168","volume":"75","author":"CS Musaeus","year":"2020","unstructured":"Musaeus CS, Gleerup HS, H\u00f8gh P, Waldemar G, Hasselbalch SG, Simonsen AH. Cerebrospinal fluid\/plasma albumin ratio as a biomarker for blood\u2013brain barrier impairment across neurodegenerative dementias. J Alzheimers Dis. 2020;75(2):429\u201336.","journal-title":"J Alzheimers Dis"},{"key":"575_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.028","volume":"59","author":"T Skillb\u00e4ck","year":"2017","unstructured":"Skillb\u00e4ck T, Delsing L, Synnergren J, Mattsson N, Janelidze S, N\u00e4gga K, Kilander L, Hicks R, Wimo A, Winblad B, et al. CSF\/serum albumin ratio in dementias: a cross-sectional study on 1861 patients. Neurobiol Aging. 2017;59:1\u20139.","journal-title":"Neurobiol Aging"},{"key":"575_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","volume":"51","author":"S Janelidze","year":"2017","unstructured":"Janelidze S, Hertze J, N\u00e4gga K, Nilsson K, Nilsson C, Wennstr\u00f6m M, van Westen D, Blennow K, Zetterberg H, Hansson O. Increased blood\u2013brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype. Neurobiol Aging. 2017;51:104\u201312.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"575_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133\u201350.","journal-title":"Nat Rev Neurol"},{"issue":"Pt B","key":"575_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.neuropharm.2017.10.034","volume":"134","author":"R Raja","year":"2018","unstructured":"Raja R, Rosenberg GA, Caprihan A. MRI measurements of blood\u2013brain barrier function in dementia: a review of recent studies. Neuropharmacology. 2018;134(Pt B):259\u201371.","journal-title":"Neuropharmacology"},{"key":"575_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2016.06.006","volume":"45","author":"HJ van de Haar","year":"2016","unstructured":"van de Haar HJ, Jansen JFA, van Osch MJP, van Buchem MA, Muller M, Wong SM, Hofman PAM, Burgmans S, Verhey FRJ, Backes WH. Neurovascular unit impairment in early Alzheimer\u2019s disease measured with magnetic resonance imaging. Neurobiol Aging. 2016;45:190\u20136.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"575_CR27","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jalz.2019.07.012","volume":"15","author":"A Montagne","year":"2019","unstructured":"Montagne A, Huuskonen MT, Rajagopal G, Sweeney MD, Nation DA, Sepehrband F, D\u2019Orazio LM, Harrington MG, Chui HC, Law M, et al. Undetectable gadolinium brain retention in individuals with an age-dependent blood\u2013brain barrier breakdown in the hippocampus and mild cognitive impairment. Alzheimers Dement. 2019;15(12):1568\u201375.","journal-title":"Alzheimers Dement"},{"issue":"17","key":"575_CR28","doi-asserted-by":"publisher","first-page":"e2192","DOI":"10.1212\/WNL.0000000000011783","volume":"96","author":"D Kerkhofs","year":"2021","unstructured":"Kerkhofs D, Wong SM, Zhang E, Staals J, Jansen JFA, van Oostenbrugge RJ, Backes WH. Baseline blood\u2013brain barrier leakage and longitudinal microstructural tissue damage in the periphery of white matter hyperintensities. Neurology. 2021;96(17):e2192\u2013200.","journal-title":"Neurology"},{"issue":"3","key":"575_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"575_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100.","journal-title":"Neurology"},{"issue":"3","key":"575_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"575_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"575_CR33","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134.","journal-title":"Neurology"},{"issue":"3","key":"575_CR34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3233\/JAD-220082","volume":"88","author":"J Gan","year":"2022","unstructured":"Gan J, Liu S, Chen Z, Yang Y, Ma L, Meng Q, Wang XD, Liu C, Li X, Zhang W, et al. Elevated plasma orexin-a levels in prodromal dementia with Lewy bodies. J Alzheimers Dis. 2022;88(3):1037\u201348.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"575_CR35","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3945\/an.117.016261","volume":"8","author":"SM Poulose","year":"2017","unstructured":"Poulose SM, Miller MG, Scott T, Shukitt-Hale B. Nutritional factors affecting adult neurogenesis and cognitive function. Adv Nutr. 2017;8(6):804\u201311.","journal-title":"Adv Nutr"},{"issue":"5","key":"575_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jmri.20699","volume":"24","author":"DL Buckley","year":"2006","unstructured":"Buckley DL, Shurrab AE, Cheung CM, Jones AP, Mamtora H, Kalra PA. Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects. J Magn Reson Imaging. 2006;24(5):1117\u201323.","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"575_CR37","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/mrm.22686","volume":"65","author":"S Taheri","year":"2011","unstructured":"Taheri S, Gasparovic C, Shah NJ, Rosenberg GA. Quantitative measurement of blood\u2013brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping. Magn Reson Med. 2011;65(4):1036\u201342.","journal-title":"Magn Reson Med"},{"issue":"2","key":"575_CR38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, et al. Blood\u2013brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296\u2013302.","journal-title":"Neuron"},{"issue":"1\u20132","key":"575_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jns.2015.10.011","volume":"358","author":"F Llorens","year":"2015","unstructured":"Llorens F, Schmitz M, Gloeckner SF, Kaerst L, Hermann P, Schmidt C, Varges D, Zerr I. Increased albumin CSF\/serum ratio in dementia with Lewy bodies. J Neurol Sci. 2015;358(1\u20132):398\u2013403.","journal-title":"J Neurol Sci"},{"issue":"2","key":"575_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cns.13775","volume":"28","author":"WY Ma","year":"2022","unstructured":"Ma WY, Tian MJ, Yao Q, Li Q, Tang FY, Xiao CY, Shi JP, Chen J. Neuroimaging alterations in dementia with Lewy bodies and neuroimaging differences between dementia with Lewy bodies and Alzheimer\u2019s disease: an activation likelihood estimation meta-analysis. CNS Neurosci Ther. 2022;28(2):183\u2013205.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"575_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171802","volume":"12","author":"S Liu","year":"2017","unstructured":"Liu S, Wang XD, Wang Y, Shi Z, Cai L, Liu S, Han T, Zhou Y, Wang X, Gao S, et al. Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies. PLoS ONE. 2017;12(3): e0171802.","journal-title":"PLoS ONE"},{"issue":"1","key":"575_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-019-0473-4","volume":"11","author":"SP Caminiti","year":"2019","unstructured":"Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, et al. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther. 2019;11(1):20.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"575_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/bpa.12130","volume":"24","author":"S Miners","year":"2014","unstructured":"Miners S, Moulding H, de Silva R, Love S. Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies. Brain Pathol. 2014;24(4):334\u201343.","journal-title":"Brain Pathol"},{"issue":"2","key":"575_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, et al. Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270\u20136.","journal-title":"Nat Med"},{"issue":"10","key":"575_CR45","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1093\/brain\/awab478","volume":"145","author":"RJ Jackson","year":"2022","unstructured":"Jackson RJ, Meltzer JC, Nguyen H, Commins C, Bennett RE, Hudry E, Hyman BT. APOE4 derived from astrocytes leads to blood\u2013brain barrier impairment. Brain. 2022;145(10):3582\u201393.","journal-title":"Brain"},{"issue":"1","key":"575_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-024-02696-z","volume":"147","author":"YC Wu","year":"2024","unstructured":"Wu YC, Bogale TA, Koistinaho J, Pizzi M, Rolova T, Bellucci A. The contribution of \u03b2-amyloid, Tau and \u03b1-synuclein to blood\u2013brain barrier damage in neurodegenerative disorders. Acta Neuropathol. 2024;147(1):39.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"575_CR47","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1177\/0271678X231180035","volume":"43","author":"Y Moon","year":"2023","unstructured":"Moon Y, Jeon HJ, Han SH, Min-Young N, Kim HJ, Kwon KJ, Moon WJ, Kim SH. Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition. J Cereb Blood Flow Metab. 2023;43(11):1813\u201325.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"575_CR48","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","volume":"76","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Janelidze S, Stomrud E, Zetterberg H, Karl J, Zink K, Bittner T, Mattsson N, Eichenlaub U, Blennow K, et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related \u03b2-amyloid status. JAMA Neurol. 2019;76(9):1060\u20139.","journal-title":"JAMA Neurol"},{"issue":"15","key":"575_CR49","doi-asserted-by":"publisher","first-page":"12151","DOI":"10.3390\/ijms241512151","volume":"24","author":"S Toniolo","year":"2023","unstructured":"Toniolo S, Di Lorenzo F, Bernardini S, Mercuri NB, Sancesario GM. Blood\u2013brain barrier dysfunction and A\u03b242\/40 ratio dose-dependent modulation with the ApoE genotype within the ATN framework. Int J Mol Sci. 2023;24(15):12151.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"575_CR50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/acn3.51482","volume":"9","author":"RL Miller","year":"2022","unstructured":"Miller RL, Dhavale DD, O\u2019Shea JY, Andruska KM, Liu J, Franklin EE, Buddhala C, Loftin SK, Cirrito JR, Perrin RJ, et al. Quantifying regional \u03b1 -synuclein, amyloid \u03b2, and tau accumulation in Lewy body dementia. Ann Clin Transl Neurol. 2022;9(2):106\u201321.","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"575_CR51","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","volume":"69","author":"PT Kotzbauer","year":"2012","unstructured":"Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS. Pathologic accumulation of \u03b1-synuclein and A\u03b2 in Parkinson disease patients with dementia. Arch Neurol. 2012;69(10):1326\u201331.","journal-title":"Arch Neurol"},{"issue":"1","key":"575_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20(1):68\u201380.","journal-title":"Lancet Neurol"},{"issue":"2","key":"575_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.220","volume":"6","author":"MJ Keogh","year":"2016","unstructured":"Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, et al. Exome sequencing in dementia with Lewy bodies. Transl Psychiatry. 2016;6(2): e728.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"575_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12883-022-02897-7","volume":"22","author":"J Gan","year":"2022","unstructured":"Gan J, Chen Z, Liu S, Shi Z, Liu Y, Wang XD, Liu C, Ji Y. The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia. BMC Neurol. 2022;22(1):355.","journal-title":"BMC Neurol"},{"issue":"1","key":"575_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-021-00771-1","volume":"13","author":"JA Pillai","year":"2021","unstructured":"Pillai JA, Bena J, Bonner-Jackson A, Leverenz JB. Impact of APOE \u03b54 genotype on initial cognitive symptoms differs for Alzheimer\u2019s and Lewy body neuropathology. Alzheimers Res Ther. 2021;13(1):31.","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"575_CR56","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN, van Gerpen JA, Uitti RJ, Wszolek ZK, Ertekin-Taner N, et al. APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology. 2018;91(12):e1182\u201395.","journal-title":"Neurology"},{"key":"575_CR57","doi-asserted-by":"publisher","first-page":"1088140","DOI":"10.3389\/fnagi.2023.1088140","volume":"15","author":"J Gan","year":"2023","unstructured":"Gan J, Yang X, Zhang G, Li X, Liu S, Zhang W, Ji Y. Alzheimer\u2019s disease pathology: pathways between chronic vascular risk factors and blood\u2013brain barrier dysfunction in a cohort of patients with different types of dementia. Front Aging Neurosci. 2023;15:1088140.","journal-title":"Front Aging Neurosci"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-024-00575-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-024-00575-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-024-00575-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T11:29:08Z","timestamp":1726745348000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-024-00575-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1186\/s12987-024-00575-z","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed according to the Helsinki Declaration and approved by the Ethical Review Board of Beijing Tiantan Hospital (KYSQ 2021-068-01). Written informed consents were obtained from all participants and family members of AD and DLB patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}